Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1992 1
1993 1
1994 2
1997 3
1998 3
1999 4
2000 4
2001 2
2003 4
2004 3
2005 4
2006 4
2007 2
2008 2
2009 6
2010 11
2011 12
2012 12
2013 3
2014 4
2015 6
2016 4
2017 7
2018 8
2019 3
2020 13
2021 10
2022 17
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
The following terms were ignored: %, %, %, %
The following terms were not found in PubMed: 22Al-Daghri, 5BAuthor
Page 1
Vacuum-deposited Rb3CeI6 for deep-blue-light-emitting diodes.
Du H, Yang L, Pang J, Shen Z, Li J, Dong X, Luo Y, Luo J, Tang J. Du H, et al. Opt Lett. 2023 Jun 1;48(11):2777-2780. doi: 10.1364/OL.486168. Opt Lett. 2023. PMID: 37262208
Herein, we vacuum thermally deposited a film of the lead-free rare earth halide Rb(3)CeI(6), which shows deep blue emission with peaks at 427 nm and 468 nm. Due to the parity-allowed 5d-4f transition of Ce(III), the excited-state lifetime is as short as 22
Herein, we vacuum thermally deposited a film of the lead-free rare earth halide Rb(3)CeI(6), which shows deep blue emission with peaks at 42 …
UV-pumped visible Tb3+-lasers.
Kalusniak S, Tanaka H, Castellano-Hernández E, Kränkel C. Kalusniak S, et al. Opt Lett. 2020 Nov 15;45(22):6170-6173. doi: 10.1364/OL.411072. Opt Lett. 2020. PMID: 33186942
The cross-relaxation process is found to efficiently populate the upper laser level (5)D(4) at doping concentrations typically used in Tb(3+)-doped gain media. Pumping with a frequency doubled Ti:sapphire laser at 359 nm enables laser operation in the green and yellow spec …
The cross-relaxation process is found to efficiently populate the upper laser level (5)D(4) at doping concentrations typically used in Tb(3+ …
Analysis of Excitation Energy Transfer in LaPO4 Nanophosphors Co-Doped with Eu3+/Nd3+ and Eu3+/Nd3+/Yb3+ Ions.
Sadowska K, Ragiń T, Kochanowicz M, Miluski P, Dorosz J, Leśniak M, Dorosz D, Kuwik M, Pisarska J, Pisarski W, Rećko K, Żmojda J. Sadowska K, et al. Materials (Basel). 2023 Feb 14;16(4):1588. doi: 10.3390/ma16041588. Materials (Basel). 2023. PMID: 36837218 Free PMC article.
Tests performed confirmed the crystal structure of the produced phosphors and deposition of rare-earth ions in the structure of LaPO(4) nanocrystals. In the range of the first biological window (650-950 nm), strong luminescence bands at the wavelengths of 687 nm and …
Tests performed confirmed the crystal structure of the produced phosphors and deposition of rare-earth ions in the structure of LaPO(4) nano …
Enhanced Depth of Focus Intraocular Lenses: Through Focus Evaluation of Wavefront-Shaping versus Diffractive Optics.
Schmid R, Borkenstein AF. Schmid R, et al. Biomed Hub. 2023 Feb 28;8(1):25-30. doi: 10.1159/000529234. eCollection 2023 Jan-Dec. Biomed Hub. 2023. PMID: 36938365 Free PMC article.
MATERIAL AND METHODS: Tecnis Symfony (diffractive) and the wavefront-shaping Acrysof IQ Vivity and LuxSmart Crystal IOLs (22 D each) were assessed by the OptiSpheric IOL PRO 2 imaging test bench with an ISO-2 cornea and a wavelength of 546 nm. ...
MATERIAL AND METHODS: Tecnis Symfony (diffractive) and the wavefront-shaping Acrysof IQ Vivity and LuxSmart Crystal IOLs (22 D each) …
Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial.
Bergman M, Tundia N, Martin N, Suboticki JL, Patel J, Goldschmidt D, Song Y, Wright GC. Bergman M, et al. Arthritis Res Ther. 2022 Jun 24;24(1):155. doi: 10.1186/s13075-022-02813-x. Arthritis Res Ther. 2022. PMID: 35751108 Free PMC article. Clinical Trial.
PROs evaluated included Patient Global Assessment of Disease Activity (PtGA) by visual analog scale (VAS), patient's assessment of pain by VAS, Health Assessment Questionnaire Disability Index (HAQ-DI), morning stiffness duration and severity, 36-Item Short Form Health Survey (SF …
PROs evaluated included Patient Global Assessment of Disease Activity (PtGA) by visual analog scale (VAS), patient's assessment of pain by V …
Thiazolopyrimidine Scaffold as a Promising Nucleus for Developing Anticancer Drugs: A Review Conducted in Last Decade.
Islam MR, Fahmy H. Islam MR, et al. Anticancer Agents Med Chem. 2022;22(17):2942-2955. doi: 10.2174/1871520622666220411110528. Anticancer Agents Med Chem. 2022. PMID: 35410622 Review.
Throughout the years, those scaffolds have been studied extensively for its anticancer properties and several compounds were designed, synthesized, and evaluated for their anticancer effects with activity in the muM to nM range. However, there are hardly any reviews coveri …
Throughout the years, those scaffolds have been studied extensively for its anticancer properties and several compounds were designed, synth …
A retrospective comparative cohort study of the effects of neural mobilization (NM) alone and NM combined with transcranial direct current stimulation in patients with cervical radiculopathy.
Chen Z, Zhang W, Yu Y, Tan T. Chen Z, et al. Ann Palliat Med. 2022 Sep;11(9):2961-2967. doi: 10.21037/apm-22-746. Ann Palliat Med. 2022. PMID: 36217625 Free article.
RESULTS: A total of 36 patients were enrolled (19 in the combined tDCS group and 17 in the NM group). The baseline VAS, NDI, and EQ-5D scores in the combined tDCS group were 54.316.4 mm, 35.114.7, and 0.620.15, respectively, while the baseline VAS, NDI, and EQ-5D
RESULTS: A total of 36 patients were enrolled (19 in the combined tDCS group and 17 in the NM group). The baseline VAS, NDI, and EQ- …
Feasibility of a novel neurofeedback system: a parallel randomized single-blinded pilot study.
Horváth D, Négyesi J, Rácz M, Győri T, Matics Z, Puskin A, Csipor J, Rácz L. Horváth D, et al. Sci Rep. 2023 Oct 13;13(1):17353. doi: 10.1038/s41598-023-44545-1. Sci Rep. 2023. PMID: 37833489 Free PMC article. Clinical Trial.
Here, we investigated the feasibility and efficacy of a novel neurofeedback system, neuroMoon (nM), on cognitive abilities compared with one of the most popular perceptual-cognitive training (PCT) tools both in sports and rehabilitation called NeuroTracker (NT). Thirty-one …
Here, we investigated the feasibility and efficacy of a novel neurofeedback system, neuroMoon (nM), on cognitive abilities compared w …
Anti-Inflammatory Activity of Soluble Epoxide Hydrolase Inhibitors Based on Selenoureas Bearing an Adamantane Moiety.
Burmistrov V, Morisseau C, Babkov DA, Golubeva T, Pitushkin D, Sokolova EV, Vasipov V, Kuznetsov Y, Bazhenov SV, Novoyatlova US, Bondarev NA, Manukhov IV, Osipova V, Berberova N, Spasov AA, Butov GM, Hammock BD. Burmistrov V, et al. Int J Mol Sci. 2022 Sep 14;23(18):10710. doi: 10.3390/ijms231810710. Int J Mol Sci. 2022. PMID: 36142611 Free PMC article.
The inhibitory potency of the series of inhibitors of the soluble epoxide hydrolase (sEH) based on the selenourea moiety and containing adamantane and aromatic lipophilic groups ranges from 34.3 nM to 1.2 muM. The most active compound 5d possesses aliphatic spacers …
The inhibitory potency of the series of inhibitors of the soluble epoxide hydrolase (sEH) based on the selenourea moiety and containing adam …
Combined effect of polycan, a β-glucan from Aureobasidium pullulans, and regular resistance exercise on muscle strength, biomarkers, and fitness profiles in adults with relatively low skeletal muscle mass: a randomised controlled trial.
Kim HJ, Shin JS, Kim WG, Lee SY. Kim HJ, et al. Food Funct. 2023 Jul 3;14(13):6236-6247. doi: 10.1039/d3fo00589e. Food Funct. 2023. PMID: 37350091 Clinical Trial.
Results: The combination of APbetaG and regular resistance exercise over 12 weeks resulted in a higher right knee flexion strength by 4.49 Nm (95% CI; -0.12-8.86 Nm; P = 0.044) than the placebo according to the intention-to-treat analysis. The combination interventi …
Results: The combination of APbetaG and regular resistance exercise over 12 weeks resulted in a higher right knee flexion strength by 4.49 …
159 results